AstraZeneca completed the acquisition of Modella AI.

AstraZeneca, a research-based biopharmaceutical company, completed the acquisition of Modella AI. a Boston-based biomedical AI company. Financial terms were not disclosed. “Modella AI was built at the intersection of pathology, clinical data, and advanced generative AI to tackle some of the hardest problems in oncology. Integrating our foundation models directly into AstraZeneca’s research ecosystem will help translate methodological advances into real-world impact faster," Faisal Mahmood, Modella AI Co-Founder.